Gender differences in Alzheimer disease: Brain atrophy, histopathology burden, and cognition

Document Type

Article

Abstract

Multiple studies suggest that females are affected by Alzheimer disease (AD) more severely and more frequently than males. Other studies have failed to confirm this and the issue remains controversial. Difficulties include differences in study methods and male versus female life expectancy. Another element of uncertainty is that the majority of studies have lacked neuropathological confirmation of the AD diagnosis. We compared clinical and pathological AD severity in 1028 deceased subjects with full neuropathological examinations. The age of dementia onset did not differ by gender but females were more likely to proceed to very severe clinical and pathological disease, with significantly higher proportions having a Mini-Mental State Examination score of 5 or less and Braak stage VI neurofibrillary degeneration. Median neuritic plaque densities were similar in females and males with AD but females had significantly greater tangle density scores. In addition, we found that AD-control brain weight differences were significantly greater for females, even after adjustment for age, disease duration, and comorbid conditions. These findings suggest that when they are affected by AD, females progress more often to severe cognitive dysfunction, due to more severe neurofibrillary degeneration, and greater loss of brain parenchyma.

Publication Date

8-1-2016

Publication Title

Journal of Neuropathology and Experimental Neurology

ISSN

00223069

E-ISSN

15546578

Volume

75

Issue

8

First Page

748

Last Page

754

Digital Object Identifier (DOI)

10.1093/jnen/nlw047

Link to Full Text

Share

COinS